Please assess the completion status of the following clinical trial:

Trial Title: Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy subjects who previously participated in study V87P1, but did not receive the booster dose on day 202~Exclusion Criteria:~* Pregnant or breastfeeding~* Receipt of another vaccine or any investigational agent within the past 4 weeks~* Surgery planned during the study period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).